- Home
- ELDN vs RMAX Comparison
ELDN vs RMAX Comparison
Compare ELDN & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- RMAX
- Stock Information
- Founded
- ELDN 2004
- RMAX 1973
- Country
- ELDN United States
- RMAX United States
- Employees
- ELDN N/A
- RMAX N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- RMAX Real Estate
- Sector
- ELDN Health Care
- RMAX Finance
- Exchange
- ELDN Nasdaq
- RMAX Nasdaq
- Market Cap
- ELDN 202.4M
- RMAX 178.3M
- IPO Year
- ELDN N/A
- RMAX 2013
- Fundamental
- Price
- ELDN $2.59
- RMAX $9.75
- Analyst Decision
- ELDN Strong Buy
- RMAX Hold
- Analyst Count
- ELDN 2
- RMAX 1
- Target Price
- ELDN $12.50
- RMAX $9.00
- AVG Volume (30 Days)
- ELDN 683.9K
- RMAX 258.9K
- Earning Date
- ELDN 08-14-2025
- RMAX 10-30-2025
- Dividend Yield
- ELDN N/A
- RMAX N/A
- EPS Growth
- ELDN N/A
- RMAX N/A
- EPS
- ELDN 0.21
- RMAX 0.48
- Revenue
- ELDN N/A
- RMAX $298,162,000.00
- Revenue This Year
- ELDN N/A
- RMAX N/A
- Revenue Next Year
- ELDN N/A
- RMAX $1.45
- P/E Ratio
- ELDN $12.78
- RMAX $20.17
- Revenue Growth
- ELDN N/A
- RMAX N/A
- 52 Week Low
- ELDN $2.38
- RMAX $6.90
- 52 Week High
- ELDN $5.54
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- ELDN 41.11
- RMAX 65.81
- Support Level
- ELDN $2.54
- RMAX $8.94
- Resistance Level
- ELDN $2.84
- RMAX $9.98
- Average True Range (ATR)
- ELDN 0.13
- RMAX 0.34
- MACD
- ELDN 0.03
- RMAX 0.04
- Stochastic Oscillator
- ELDN 22.73
- RMAX 84.30
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.